質譜分析的全球市場:成長，趨勢及預測(2017年∼2022年)

質譜分析（MS）是一種分析化學技術，測量質量電荷比和氣相離子的豐度來幫助識別樣品中化學物的數量和類型。質譜市場根據所用的技術或平台分為不同的類型。這些包括單質譜，混合或串聯質譜以及其他形式的質譜。在所有細分市場中，混合質譜法顯示出廣泛的應用，因此與其他平台相比具有最高的市場佔有率。在過去五年中，LC-MS技術（包括三重四極桿，離子阱，Q-TOF和FT-MS）的技術革新具有革命性意義，並為研究人員提供了獲取更多訊息的工具，以滿足市場需求。

本報告提供全球質譜分析市場調查，整體市場趨勢各，產品、地區的詳細趨勢，市場成長的影響要素分析，競爭情形，主要企業簡介等，總括性彙整。

目錄

第1章 簡介

• 研究救濟策略
• 市場定義
• 數量單位
• 基本貨幣
• 檢討和預報期間的年齡
• 調查的一般前提條件

第2章 調查方法

• 簡介
• 分析方法論
• 計量經濟學的預測模式
• 調查的前提條件

第3章 摘要整理

第4章 主要推論

第5章 市場概況及產業趨勢

• 目前市場方案
• 技術概要
• 治療藥新的發展
• 投資分析
• 波特的五力分析
  • 供應商談判力
  • 買主談判力
  • 競爭程度
  • 替代品的威脅
  • 新加入廠商的威脅

第6章 成長要素，阻礙因素，機會及課題分析(DROC)

• 市場成長要素
  • 在生命科學研究的政府支出的增加
  • 製藥產業的研究開發費的增加
  • 對食品的關注在食品、飲料產業中高漲
• 市場阻礙因素
  • 設備的成本
  • 技術純熟勞工的缺乏
• 市場機會
  • 水中的微量污染物質的監測
  • 蛋白質體學
  • 功能基因學
• 主要課題

第7章 市場區隔

• 各技術
  • 單一質譜分析
  • 混合質譜分析
• 各產品
  • 設備
  • 試劑及消耗品
  • 服務
• 各應用領域
  • 醫藥品
  • 生物科技
  • 工業化學
  • 環境實驗
  • 食品、飲料的實驗
  • 醫學研究

第10章 各地區市場:各地區佔有率及預測

• 北美
  • 簡介
  • 美國
  • 加拿大
  • 其他
• 歐洲
  • 簡介
  • 法國
  • 英國
  • 德國
  • 西班牙
  • 俄羅斯
  • 義大利
  • 其他
• 亞太地區
  • 簡介
  • 印度
  • 中國
  • 日本
  • 韓國
  • 澳洲
  • 其他
• 中東、非洲地區
  • 簡介
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 以色列
  • 其他MEA各國
• 中南美
  • 簡介
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他

第11章 競爭情形

第12章 主要供應商

• Agilent Technologies
• Danaher Corporation
• PerkinElmer Inc
• Thermo Fisher Scientific
• Bruker Corporation
• Waters Corporation
• 株式會社島津製作所
• Leco Corporation.
• Dani Instruments S.P.A.

第13章 分析師的投資機會預測

第14章 市場未來展望

第8章 附錄

• 簡稱
• 參考文獻
• 免責聲明

Market Overview

The mass spectrometry market is expected witness a CAGR of 7.27% during the forecast period. Certain factors that are driving the market growth include the increasing technological advancement, growing concerns over food safety, and rising R&D expenditure by the pharmaceutical industry and government research organizations.

Mass spectrometry (MS) is one of the most powerful tools used for the analyses of a wide range of chemical and biological entities. In addition, the high demand and resulting requirements from the pharmaceutical and biotechnology industries are the main driving factors for some extraordinary recent advances in mass spectrometry technology. The advancements in mass spectroscopy technology were able to increase the factors like rapid test results with high resolution. The discovery of new tools and software has the potential to stimulate the usage of mass spectroscopy across drugs development, proteomics, pharmaceuticals, food safety testing, and many other fields. The demands of the life sciences applications have led to the improvement of MS technologies and the rapid growth of new types of instruments. New mass spectrometry methods, collectively known as data independent analysis and hyper reaction monitoring, have recently emerged. Understanding complexity related to cancer biology requires extensive information about the cancer proteome over the course of the disease. Hence, with the increasing technological advancement, the market is expected to grow.

Scope of the Report

As per the scope of this report, mass spectrometry (MS) is an analytical chemistry technique used to identify the amount and type of chemical species present in a sample, by measuring the mass-to-charge ratio and abundance of gas phase ions.

Key Market Trends

Triple Quadrupole (Tandem) is Expected to Hold Significant Market Share in the Type of Hybrid Mass Spectrometry

Tandem mass spectrometry devices are currently among the most in demand. Conventional hospital diagnostic assays are based on clinical chemistry and immunoassay techniques that require analyte specific reagents and antibodies. LC-MS/MS-based approaches are considered reagent-free. The high specificity and sensitivity of LC-MS/MS overcome many limitations associated with the traditional immunoassays, such as non-specific antibody binding and cross-reactivity. There is a higher demand for hybrid instruments, such as triple quadrupole mass spectrometer, quadrupole time-of-flight mass spectrometer, etc. Currently, triple quadrupole MS is considered one of the most high-end instruments and many labs across the world are adopting this instrument.

North America Dominates the Market and Expected to do the Same in the Forecast Period

According to the Industrial Research Institute (IRI) report, the United States spends the world's highest (i.e., USD 516 billion) amount for research and development, currently. The United States spends 43% of the total life sciences/healthcare research and development and 56% of pharmaceutical/biotech R&D spending worldwide. Research and development include drug development and fundamental science research. Drug development, from the initial discovery to the final medication, is an expensive and lengthy process, and the failure rate is also high. High cost, lengthy time period, and the high failure rate are forcing researchers and drug manufacturing companies to look for newer technology, which can improve the process and reduce the cost at the same time. Mass spectrometry has the potential to do the same. It makes a functional and structural study, which takes a significant amount of time and resource in drug development, for the molecule, easier and faster.

Competitive Landscape

The mass spectrometry market is highly competitive and consists of a few major players. Companies like Agilent Technologies, Bruker Corporation, Danaher Corporation, Dani instruments s.p.a, Leco Corporation, Perkin Elmer Inc., Shimadzu Corporation, Thermo Fisher Scientific, and Waters Corporation, among others, hold the substantial market share in the mass spectrometry market.

Reasons to Purchase this report:

• The market estimate (ME) sheet in Excel format
• Report customization as per the client's requirements
• 3 months of analyst support

Table of Contents

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Technological Advancement
  • 4.2.2 Growing Concerns Over Food Safety
  • 4.2.3 Rising R&D Expenditure By Pharmaceutical Industry & Government Research Organizations
• 4.3 Market Restraints
  • 4.3.1 High Cost Of Instrument
  • 4.3.2 Lack Of Skilled Technicians
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 Technology
  • 5.1.1 Hybrid Mass Spectrometry
    • 5.1.1.1 Triple Quadrupole (Tandem)
    • 5.1.1.2 Quadrupole TOF (Q-TOF)
    • 5.1.1.3 FTMS (Fourier Transform Mass Spectrometry)
  • 5.1.2 Single Mass Spectrometry
    • 5.1.2.1 ION Trap
    • 5.1.2.2 Quadrupole
    • 5.1.2.3 Time-of-Flight (TOF)
  • 5.1.3 Other Mass Spectrometry
• 5.2 Application
  • 5.2.1 Pharmaceuticals Industry
  • 5.2.2 Biotechnology Industry
  • 5.2.3 Chemical Industry
  • 5.2.4 Environmental Testing
  • 5.2.5 Food and Beverage Testing
  • 5.2.6 Other Applications
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 US
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 UK
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East & Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East & Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Agilent Technologies
  • 6.1.2 Bruker Corporation
  • 6.1.3 Danaher Corporation
  • 6.1.4 Dani Instruments
  • 6.1.5 Leco Corporation
  • 6.1.6 Perkin elmer Inc.
  • 6.1.7 Shimadzu Corporation
  • 6.1.8 Thermo Fisher Scientific
  • 6.1.9 Waters Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS